Published on IRCCS materno infantile Burlo Garofolo (https://www.burlo.trieste.it)

Home > Printer-friendly > Anti-leukemic activity of dasatinib in both p53(wild-type) and p53(mutated) B malignant cells.

Anti-leukemic activity of dasatinib in both p53(wild-type) and p53(mutated) B malignant cells. [1]

TitoloAnti-leukemic activity of dasatinib in both p53(wild-type) and p53(mutated) B malignant cells.
Publication TypeJournal Article
AuthorsBosco, R [2], Rabusin, M [3], Voltan, R [4], Celeghini, C [5], Corallini, F [6], Capitani, S [7], Secchiero, P [8]
PubMed ID20953816 [9]

Source URL: https://www.burlo.trieste.it/ricerca/pubblicazioni/anti-leukemic-activity-dasatinib-both-p53wild-type-and-p53mutated-b-malignant-cells#comment-0

Collegamenti
[1] https://www.burlo.trieste.it/ricerca/pubblicazioni/anti-leukemic-activity-dasatinib-both-p53wild-type-and-p53mutated-b-malignant-cells
[2] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=222
[3] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=223
[4] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=224
[5] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=225
[6] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=99
[7] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=226
[8] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=98
[9] http://www.ncbi.nlm.nih.gov/pubmed/20953816?dopt=Abstract